Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial

[1]  M. Hersberger,et al.  Adrenergic Receptor Genotype but Not Perioperative Bisoprolol Therapy May Determine Cardiovascular Outcome in At-risk Patients Undergoing Surgery with Spinal Block: The Swiss Beta Blocker in Spinal Anesthesia (BBSA) Study: A Double-blinded, Placebo-controlled, Multicenter Trial with 1-Year Follow-up , 2007, Anesthesiology.

[2]  Homer Yang,et al.  The effects of perioperative β-blockade: Results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial , 2006 .

[3]  G. Guyatt,et al.  Rationale, design, and organization of the PeriOperative ISchemic Evaluation (POISE) trial: a randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgery. , 2006, American heart journal.

[4]  P. L. Petersen,et al.  Effect of perioperative β blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial , 2006, BMJ : British Medical Journal.

[5]  R. Collins,et al.  Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial , 2005, The Lancet.

[6]  R. Collins,et al.  Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial , 2005, The Lancet.

[7]  L. Goldman,et al.  Surveillance and prevention of major perioperative ischemic cardiac events in patients undergoing noncardiac surgery: a review , 2005, Canadian Medical Association Journal.

[8]  Gordon H. Guyatt,et al.  Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk , 2005, Canadian Medical Association Journal.

[9]  P. Lindenauer,et al.  Perioperative beta-blocker therapy and mortality after major noncardiac surgery. , 2005, The New England journal of medicine.

[10]  L. Sleeper,et al.  Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. , 2005, Archives of internal medicine.

[11]  Gordon H Guyatt,et al.  How strong is the evidence for the use of perioperative β blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials , 2005, BMJ : British Medical Journal.

[12]  J. Powell,et al.  Regarding "Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial". , 2005 .

[13]  M. Sydes,et al.  Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. , 2005, Journal of vascular surgery.

[14]  G. Guyatt,et al.  Are the recommendations to use perioperative β-blocker therapy in patients undergoing noncardiac surgery based on reliable evidence? , 2004, Canadian Medical Association Journal.

[15]  K. Egstrup,et al.  The antianginal efficacy and tolerability of controlled-release metoprolol once daily: A comparison with conventional metoprolol tablets twice daily , 2004, European Journal of Clinical Pharmacology.

[16]  P. Lundborg,et al.  Pharmacokinetics and pharmacodynamics of controlled-release metoprolol: A comparison with atenolol , 2004, European Journal of Clinical Pharmacology.

[17]  M. Blaser,et al.  Population attributable risks of esophageal and gastric cancers. , 2003, Journal of the National Cancer Institute.

[18]  T. Sheldon.  Dutch neurologist found guilty of fraud after falsifying 438 case records , 2002, BMJ : British Medical Journal.

[19]  P. Kligfield,et al.  Postoperative Prophylactic Administration of &bgr;-Adrenergic Blockers in Patients at Risk for Myocardial Ischemia , 2000, Anesthesia and analgesia.

[20]  Jeroen J. Bax,et al.  The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. , 1999, The New England journal of medicine.

[21]  D. Reich,et al.  Beneficial Effects from β-Adrenergic Blockade in Elderly Patients Undergoing Noncardiac Surgery , 1999 .

[22]  F. Moore.  The role of the gastrointestinal tract in postinjury multiple organ failure. , 1999, American journal of surgery.

[23]  D. Mangano.  Peri-operative cardiovascular morbidity: new developments , 1999 .

[24]  E F Cook,et al.  Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. , 1999, Circulation.

[25]  Gries,et al.  Perioperative catecholamine changes in cardiac risk patients , 1999, European journal of clinical investigation.

[26]  Farris K. Timimi,et al.  The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. , 1999, Anesthesia and analgesia.

[27]  D. Massel,et al.  Propranolol for the prevention of postoperative arrhythmias in general thoracic surgery. , 1999, The Annals of thoracic surgery.

[28]  Prophylactic Atenolol Reduces Postoperative Myocardial Ischemia , 1998 .

[29]  C. Jakobsen,et al.  Preoperative metoprolol improves cardiovascular stability and reduces oxygen consumption after thoracotomy , 1997, Acta anaesthesiologica Scandinavica.

[30]  A. Wallace,et al.  Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. , 1996, The New England journal of medicine.

[31]  M. Breslow,et al.  Catecholamine and cortisol responses to lower extremity revascularization: correlation with outcome variables. Perioperative Ischemia Randomized Anesthesia Trial Study Group. , 1995, Critical care medicine.

[32]  J. Neaton,et al.  A case of data alteration in the Multiple Risk Factor Intervention Trial (MRFIT). The MRFIT Research Group. , 1991, Controlled clinical trials.

[33]  J. Sear,et al.  Risk of myocardial ischaemia during anaesthesia in treated and untreated hypertensive patients. , 1988, British journal of anaesthesia.

[34]  P. Armitage,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. , 1976, British Journal of Cancer.

[35]  J. Haybittle,et al.  Repeated assessment of results in clinical trials of cancer treatment. , 1971, The British journal of radiology.